<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Biol Chem</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Biol. Chem</journal-id>
<journal-id journal-id-type="hwp">jbc</journal-id>
<journal-id journal-id-type="pmc">jbc</journal-id>
<journal-id journal-id-type="publisher-id">JBC</journal-id>
<journal-title-group>
<journal-title>The Journal of Biological Chemistry</journal-title>
</journal-title-group>
<issn pub-type="ppub">0021-9258</issn>
<issn pub-type="epub">1083-351X</issn>
<publisher>
<publisher-name>American Society for Biochemistry and Molecular Biology</publisher-name>
<publisher-loc>11200 Rockville Pike, Suite 302, Rockville, MD 20852-3110, U.S.A.</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27994051</article-id>
<article-id pub-id-type="pmc">5270476</article-id>
<article-id pub-id-type="publisher-id">R116.766782</article-id>
<article-id pub-id-type="doi">10.1074/jbc.R116.766782</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Minireviews</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Reelin: Neurodevelopmental Architect and Homeostatic Regulator of Excitatory Synapses<xref ref-type="fn" rid="FN1">*</xref></article-title>
<alt-title alt-title-type="short">MINIREVIEW: Reelin at the Synapse</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wasser</surname>
<given-names>Catherine R.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>‡</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>§</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Herz</surname>
<given-names>Joachim</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>‡</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>§</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>¶</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>‖</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>1</sup>
</xref>
</contrib>
<aff id="aff1">From the <label>‡</label>Department of Molecular Genetics, </aff>
<aff id="aff2"><label>¶</label>Department of Neuroscience, </aff>
<aff id="aff3"><label>§</label>Center for Translational Neurodegeneration Research, and </aff>
<aff id="aff4"><label>‖</label>Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, Texas, 75390</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>1</label> To whom correspondence should be addressed. E-mail: <email>Joachim.Herz@UTSouthwestern.edu</email>.</corresp>
<fn fn-type="edited-by">
<p>Edited by Paul E. Fraser</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>27</day>
<month>1</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>19</day>
<month>12</month>
<year>2016</year>
</pub-date>
<volume>292</volume>
<issue>4</issue>
<fpage>1330</fpage>
<lpage>1338</lpage>
<permissions>
<copyright-statement>© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>The American Society for Biochemistry and Molecular Biology, Inc.</copyright-holder>
</permissions>
<self-uri content-type="pdf" xlink:href="zbc00417001330.pdf"></self-uri>
<abstract>
<p>Over half a century ago, D. S. Falconer first reported a mouse with a reeling gate. Four decades later, the <italic>Reln</italic> gene was isolated and identified as the cause of the <italic>reeler</italic> phenotype. Initial studies found that loss of Reelin, a large, secreted glycoprotein encoded by the <italic>Reln</italic> gene, results in abnormal neuronal layering throughout several regions of the brain. In the years since, the known functions of Reelin signaling in the brain have expanded to include multiple postdevelopmental neuromodulatory roles, revealing an ever increasing body of evidence to suggest that Reelin signaling is a critical player in the modulation of synaptic function. In writing this review, we intend to highlight the most fundamental aspects of Reelin signaling and integrate how these various neuromodulatory effects shape and protect synapses.</p>
</abstract>
<kwd-group>
<kwd>amyloid-β (Aβ)</kwd>
<kwd>apolipoprotein E (ApoE)</kwd>
<kwd>neurodegeneration</kwd>
<kwd>neurotransmitter receptor</kwd>
<kwd>receptor</kwd>
<kwd>tyrosine-protein kinase (tyrosine kinase)</kwd>
<kwd>protein-tyrosine kinase</kwd>
<kwd>ApoE receptors</kwd>
<kwd>Reelin</kwd>
<kwd>synaptic function</kwd>
<kwd>neurodegenerative diseases</kwd>
</kwd-group>
<funding-group>
<award-group id="award1">
<funding-source>BrightFocus Foundation
<named-content content-type="funder-id">http://dx.doi.org/10.13039/100006312</named-content></funding-source>
</award-group>
<award-group id="award2">
<funding-source>Consortium for Frontotemporal Dementia Research</funding-source>
</award-group>
<award-group id="award3">
<funding-source>National Institutes of Health
<named-content content-type="funder-id">http://dx.doi.org/10.13039/100000002</named-content></funding-source>
<award-id>HL063762</award-id>
<award-id>NS093382</award-id>
<award-id>AG053391</award-id>
</award-group>
</funding-group>
</article-meta>
</front>
</article>
</pmc-articleset>